QuartzBio helps clinical-stage biopharma teams manage and analyze sample and biomarker data.
Based in Frederick, US, QuartzBio provides sample and biomarker intelligence tools for clinical-stage biopharma teams. Its platform connects clinical, sample, and biomarker data and supports sample tracking, quality control, indexing, and mapping. The company serves approximately 25% of top pharmaceutical companies and 20% of leading biotechnology firms, primarily in North America and Europe. In May 2026, Eir Partners led an investment with undisclosed terms to support product development and automation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in